Biotech · Private company · Morrisville, NC, US
Locus Biosciences
Track this companyFree. Adds Locus Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- LBP-EC01Phase 2 · Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- LBP-EC01 0.01x IV DosePhase 2 · Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- LBP-EC01 0.1 x IV dosePhase 2 · Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- LBP-EC01 IV Infusion DosePhase 2 · Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- TMP/SMXPhase 2 · Urinary Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)PHASE2 · RECRUITING · started Jul 13, 2022ClinicalTrials.gov NCT05488340 · fetched Nov 12, 2026
- Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. ColiPHASE1 · COMPLETED · started Dec 30, 2019ClinicalTrials.gov NCT04191148 · fetched Nov 12, 2026
NIH awards2
- Development of Therapeutic Candidates for Antibiotic Resistant Bacteria Fiscal year 2026 · $4.6MNIH RePORTER 75N93025C00035-P00002-9999-1 · fetched Nov 12, 2026
- Development of Therapeutic Candidates for Antibiotic Resistant Bacteria Fiscal year 2025 · $3.3MNIH RePORTER 75N93025C00035-0-9999-1 · fetched Nov 12, 2026